98%
921
2 minutes
20
Background: Laparoscopic hepatic cyst deroofing (LHCD) stands as the preferred treatment modality for simple hepatic cysts (SHCs), but it has limitations. This study aimed to introduce endoscopic transgastric hepatic cyst deroofing (ETGHCD) as a minimally invasive alternative and to compare its safety and efficacy with LHCD in treating SHCs.
Methods: We retrospectively enrolled 10 patients with 15 symptomatic SHCs treated by ETGHCD and 53 patients with 72 SHCs treated by LHCD at Shanghai General Hospital from June 2021 to August 2024. Based on anatomical complexity, patients were categorized into a standard-difficulty laparoscopy group (S2, S3, S5, S6, S4-inferior) and a high-difficulty laparoscopy group (S1, S7, S8, S4-superior). Comparisons were performed in patient characteristics, treatment outcomes, and follow-up data in each group.
Results: ETGHCD and LHCD were comparable in safety and both achieved a 100% success rate with complete symptom relief, with no serious complications reported. Notably, the ETGHCD group exhibited significantly lower post-procedure pain scores (0.40 ± 0.52) than the LHCD group (5.81 ± 2.94). During a median follow-up of 22.4 months, no symptom recurrences occurred in the ETGHCD group, whereas 3 patients (5.7%) in the LHCD group experienced recurrences. Both treatments significantly reduced cyst volume (ETGHCD: 85.97 ± 10.93%, LHCD: 77.28 ± 27.22%). Stratified analysis by liver segment revealed that ETGHCD achieved more favorable outcomes for the patients in the high-difficulty laparoscopy group, but no difference for the patients in the standard-difficulty laparoscopy group.
Conclusion: ETGHCD demonstrated comparable safety and efficacy to LHCD in treating SHCs, with reduced post-procedure pain and potential benefits for treating SHCs in S1, S7, S8, S4-superior.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00464-025-11711-7 | DOI Listing |
Pain Manag
September 2025
Minimally Invasive Gynecologic Surgery, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Background: Gynecologic enhanced recovery after surgery (ERAS) pathways have been developed to reduce postoperative narcotic use through multimodal pain management. While incisional injection of local anesthetic is standard practice, regional nerve blockades using liposomal agents are emerging as a promising adjunct technique for post-laparoscopy pain. Current data are conflicting regarding the benefits of regional nerve blocks on postoperative pain after laparoscopic hysterectomy.
View Article and Find Full Text PDFCancer Rep (Hoboken)
September 2025
Jian-Zhao Yin Department of Gynecology and Wei-Feng Gao Department of Anesthesiology, Gansu Provincial Hospital, Lanzhou, Gansu, China.
Background: The existing research data cannot fully prove the advantages of single-site Da Vinci robotic surgery (RSS) compared with single-site laparoscopic surgery (LESS) in the treatment of gynecological diseases.
Aims: To evaluate the effectiveness and cost of RSS and LESS in the treatment of gynecological diseases. To provide a theoretical basis for RSS to replace LESS in the treatment of gynecological diseases.
Arch Esp Urol
August 2025
Department of Urology, Kartal Dr. Lutfi Kirdar City Hospital, 34865 Istanbul, Turkey.
Background: Percutaneous nephrolithotomy (PNL) is a gold-standard procedure for managing complex kidney stones. It is traditionally performed in the prone position. Supine PNL offers benefits, such as enhanced ergonomics and simultaneous retrograde surgery.
View Article and Find Full Text PDFMedicine (Baltimore)
September 2025
Department of Obstetrics and Gynecology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey.
This study aimed to compare different hysterectomy techniques regarding postsurgical pain. Women who underwent hysterectomy for nonmalignant etiologies between January 2019 and March 2023 were included in this retrospective study. The participants were divided into 4 groups based on the surgical techniques performed: abdominal hysterectomy (AH), laparoscopic hysterectomy, vaginal hysterectomy, and vaginal natural orifice transluminal endoscopic surgery (vNOTES).
View Article and Find Full Text PDFJ Obstet Gynaecol Res
September 2025
Department of Obstetrics and Gynecology, Kawasaki Medical School, Okayama, Japan.
Aim: This study aimed to compare short- and long-term surgical outcomes between robotic sacrocolpopexy (RSC) and laparoscopic sacrocolpopexy (LSC), performed with concomitant total hysterectomy, in patients with symptomatic pelvic organ prolapse (POP).
Methods: This retrospective cohort study included 167 women who underwent RSC (n = 113) or LSC (n = 54) with hysterectomy for uterine prolapse at Kawasaki Medical University between March 2020 and December 2024. Perioperative parameters, complications (Clavien-Dindo classification), and POP recurrence were assessed.